Sakar Healthcare Stock Screener | Share Price & Fundamental Analysis
SAKAR
Pharmaceuticals
Screen Sakar Healthcare share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price NSE
₹397.10
▼
-13.65 (-3.32%)
Market Cap
₹906.46 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
3.05
EPS (TTM)
₹7.97
Dividend Yield
-
Debt to Equity
0.30
52W High
₹426.90
52W Low
₹346.45
Operating Margin
20.00%
Profit Margin
8.47%
Revenue (TTM)
₹59.00
EBITDA
₹13.00
Net Income
₹5.00
Total Assets
₹415.00
Total Equity
₹286.00
Sakar Healthcare Share Price History - Stock Screener Chart
Screen SAKAR historical share price movements with interactive charts. Analyze price trends and patterns.
Sakar Healthcare Company Profile - Fundamental Screener
Screen Sakar Healthcare company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for SAKAR shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE732S01012
Sakar Healthcare Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen SAKAR balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total Assets | 415 | 389 | 336 | 268 | 178 | 115 |
| Current Assets | 89 | 72 | 56 | 50 | 34 | 22 |
| Fixed Assets | 309 | 314 | 267 | 205 | 69 | 66 |
| Liabilities | ||||||
| Total Liabilities | 415 | 389 | 336 | 268 | 178 | 115 |
| Current Liabilities | 67 | 67 | 109 | 94 | 46 | 20 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||
| Total Equity | 286 | 262 | 173 | 128 | 99 | 81 |
| Share Capital | 22 | 22 | 19 | 17 | 16 | 15 |
| Reserves & Surplus | 261 | 236 | 154 | 110 | 83 | 66 |
Screen SAKAR income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec | 2023-Sept | 2023-Jun | 2023-Mar | 2022-Dec | 2022-Sept | 2022-Jun | 2022-Mar |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 59 | 53 | 50 | 44 | 43 | 42 | 44 | 38 | 35 | 41 | 43 | 35 | 31 | 29 | 38 |
| Expenses | 46 | 40 | 35 | 32 | 31 | 31 | 32 | 28 | 25 | 30 | 33 | 25 | 22 | 21 | 28 |
| EBITDA | 13 | 13 | 16 | 12 | 12 | 11 | 12 | 9 | 10 | 11 | 10 | 11 | 9 | 8 | 10 |
| Operating Profit % | 20.00% | 24.00% | 31.00% | 27.00% | 27.00% | 26.00% | 25.00% | 24.00% | 27.00% | 23.00% | 19.00% | 26.00% | 28.00% | 28.00% | 25.00% |
| Depreciation | 6 | 6 | 6 | 5 | 5 | 5 | 5 | 4 | 4 | 5 | 4 | 4 | 4 | 4 | 3 |
| Interest | 2 | 2 | 4 | 1 | 2 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 |
| Profit Before Tax | 5 | 5 | 6 | 6 | 5 | 5 | 5 | 3 | 4 | 4 | 4 | 5 | 4 | 4 | 6 |
| Tax | 1 | 1 | 1 | 1 | 0 | 2 | 2 | 1 | 1 | 1 | 0 | 1 | 3 | 1 | -3 |
| Net Profit | 5 | 5 | 6 | 5 | 5 | 2 | 3 | 2 | 4 | 3 | 4 | 4 | 2 | 3 | 9 |
| EPS | 2.03 | 2.11 | 2.66 | 2.08 | 2.17 | 1.10 | 1.46 | 0.98 | 1.68 | 1.46 | 2.04 | 2.16 | 1.01 | 1.65 | 5.07 |
Sakar Healthcare Cash Flow Screener - Liquidity Fundamentals
Screen SAKAR cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March |
|---|---|---|---|---|---|---|
| Operating Activities | 34 | 25 | 33 | 36 | 15 | 19 |
| Investing Activities | -31 | -52 | -74 | -90 | -47 | -22 |
| Financing Activities | -4 | 27 | 41 | 55 | 32 | 4 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 |
Screen SAKAR shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 53.58% | 52.86% | 52.86% | 53.15% | 53.15% | 53.15% | 53.58% | 60.72% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 15.93% | 15.86% | 16.01% | 16.78% | 16.80% | 16.88% | 15.75% | 18.41% |
| Other Holding | 30.48% | 31.28% | 31.13% | 30.07% | 30.05% | 29.97% | 30.67% | 20.87% |
| Shareholder Count | 8,608 | 8,115 | 7,565 | 7,386 | 7,313 | 7,867 | 8,598 | 6,322 |
Sakar Healthcare Dividend Screener - Share Yield Analysis
Screen SAKAR dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
Sakar Healthcare Index Membership - Market Screener Classification
Screen SAKAR by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Sakar Healthcare Market Events Screener - Corporate Actions
Screen SAKAR market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | -2.20% | ||
| 2025-11-07 | 2025-11-07 | Quarterly Result Announcement | NA | 8.00% |
| 2025-05-15 | 2025-05-15 | Quarterly Result Announcement | NA | 15.50% |
| 2025-02-08 | 2025-02-08 | Quarterly Result Announcement | NA | 0.83% |
| 2024-10-22 | 2024-10-22 | Quarterly Result Announcement | NA | -0.03% |
| 2023-12-20 | 2023-12-20 | Extraordinary General Meeting | NA | -5.45% |
Sakar Healthcare Competitors Screener - Peer Comparison
Screen SAKAR competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 412,734 | 39.30 | 54,729 | 9.71% | 10,980 | 39.06 |
| Divis Laboratories | 168,851 | 68.25 | 9,712 | 18.67% | 2,191 | 44.96 |
| Torrent Pharmaceuticals | 129,357 | 59.98 | 11,539 | 6.99% | 1,911 | 59.35 |
| Cipla | 120,557 | 22.21 | 28,410 | 7.12% | 5,291 | 42.76 |
| Dr Reddys Laboratories | 105,645 | 18.46 | 33,741 | 16.73% | 5,725 | 49.97 |
| Lupin | 95,023 | 21.85 | 22,910 | 13.74% | 3,306 | 50.10 |
| Zydus Life Science | 90,707 | 18.09 | 23,511 | 18.55% | 4,615 | 34.06 |
| Mankind Pharma | 88,846 | 50.78 | 12,744 | 20.90% | 2,007 | 40.67 |
| Aurobindo Pharma | 68,901 | 20.36 | 32,346 | 9.43% | 3,484 | 46.33 |
| Alkem Laboratories | 65,390 | 27.28 | 13,458 | 3.70% | 2,216 | 37.45 |
Sakar Healthcare Company Announcements - News Screener
Screen SAKAR latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2025-12-29 | Trading Window | View |
| 2025-12-19 | General Updates | View |
| 2025-11-17 | Analysts/Institutional Investor Meet/Con. Call Updates | View |
| 2025-11-11 | General Updates | View |
| 2025-11-11 | Analysts/Institutional Investor Meet/Con. Call Updates | View |
| 2025-11-11 | Press Release | View |
| 2025-11-07 | Outcome of Board Meeting | View |
| 2025-11-07 | Outcome of Board Meeting | View |
| 2025-11-06 | Analysts/Institutional Investor Meet/Con. Call Updates | View |
| 2025-11-06 | General Updates | View |
| 2025-10-10 | Updates | View |
| 2025-09-27 | Outcome of Board Meeting | View |
| 2025-09-27 | Cessation | View |
| 2025-09-27 | Cessation | View |
| 2025-09-27 | General Updates | View |
| 2025-09-25 | Trading Window | View |
| 2025-09-23 | Cessation | View |
| 2025-09-23 | Shareholders meeting | View |
| 2025-09-23 | General Updates | View |
| 2025-09-23 | Cessation | View |